ArticleJournal of physiology and biochemistry2018

miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.

Yi Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.